TABLE 2.
Strain or plasmidc | Growth rate (h−1) ona:
|
|||||||
---|---|---|---|---|---|---|---|---|
C6 | C8 | C10c | C11c | C12 | C13 | C14 | C16 | |
GPo1 | 0.49 | 0.31 | 0.20 | 0.094 | 0.063 | 0.018 | 0 | 0 |
GPo12(pCom8-alkB-GPo1) | 0.41 | 0.32 | 0.21 | 0.087 | 0.056 | 0.017 | 0 | 0 |
GPo12(pCom8-alkB-GPo1-W55S) | 0.38 | 0.28 | 0.20 | 0.11 | 0.092 | 0.047 | 0 | 0 |
GPo12(pCom8-alkB-GPo1-W55C) | 0.35 | 0.27 | 0.21 | 0.12 | 0.090 | 0.046 | 0 | 0 |
GPo12(pCom8-alkB1-AP1) | 0.28 | 0.25 | 0.081 | 0.0087 | 0 | 0 | ||
CHA0b | 0.019 | 0.019 | 0.053 | |||||
KOB2Δ1(pCom8-alkB-GPo1) | 0.009 | 0.013 | 0.0069 | 0.0020 | 0 | 0 | ||
KOB2Δ1(pCom8-alkB-GPo1-W55S) | 0.0083 | 0.012 | 0.0068 | 0.0075 | 0.011 | 0.012 | ||
KOB2Δ1(pCom8-alkB-GPo1-W55C) | 0.0087 | 0.012 | 0.0070 | 0.0077 | 0.012 | 0.013 | ||
KOB2Δ1(pCom8-alkB1-AP1) | 0 | 0 | 0 | 0 | 0 | 0 | ||
KOB2Δ1*(pCom8-alkB1-AP1) | 0.028 | 0.021 | 0.026 | 0.0091 | 0 | 0 | ||
KOB2Δ1*(pCom8-alkB1-AP1-W58S) | 0.018 | 0.023 | 0.027 | 0.017 | 0.035 | 0.017 | ||
KOB2Δ1*(pCom8-alkB1-AP1-W58L) | 0.014 | 0.024 | 0.022 | 0.0076 | 0.0051 | 0 | ||
KOB2Δ1(pCom8-alkB-H37Rv) | 0.025 | 0.027 | 0.043 | 0.043 | 0.041 | 0.038 | ||
KOB2Δ1(pCom8-alkB-H37Rv-L69F) | 0.024 | 0.0081 | 0 | 0 | 0 | 0 | ||
KOB2Δ1(pCom8-alkB-H37Rv-L69W) | 0.011 | 0.0053 | 0 | 0 | 0 | 0 |
Average growth rates of two parallel cultures inoculated from the same preculture (in all cases, the difference in growth rate was less than 10%). To reduce the toxicity of C10 and C11 to KOB2Δ1 recombinants, these alkanes were diluted in heptamethylnonane (1:3 for C10 and 1:1 for C11).
Data are from reference 27.
*, uncharacterized mutation in KOB2Δ1 that allows functional expression of AP1 AlkB1.